Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.
Pseudomonas aeruginosa uses a dedicated type III secretion system to deliver toxins directly into the cytoplasm of host cells. While progress has been made in elucidating the function of type III-secreted toxins in vitro, the in vivo functions of the type III-secreted exoenzymes are less well understood, particularly for the sequenced strain PAO1. Therefore, we have systematically deleted the genes for the three known type III effector molecules (exoS, exoT, and exoY) in P. aeruginosa PAO1 and assayed the effect of the deletions, both singly and in combination, on cytotoxicity in vitro and in vivo. We found that the type III secretion system acts differently on different cell types, causing an exoST-dependent rounding of a lung epithelial-like cell line in contrast to causing an exoSTY-independent but translocase (popB)-dependent lysis of a macrophage cell line. We utilized an in vivo competitive infection model to test each of our mutants, examining replication in the lung and spread to secondary sites such as the blood and spleen. Type III mutants inoculated intranasally exhibited only a minor defect in replication and survival in the lung, but popB and exoSTY triple mutants were profoundly defective in their ability to spread systemically. Intravenous injection of the mutants indicated that the type III secretion machinery is required for survival in the blood. Furthermore, our findings suggest that the effector-independent popB-dependent cytotoxicity that we and others have observed in vitro in macrophage cell lines may not be of great importance in vivo.
Vance
Russell E
RE
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA.
Rietsch
Arne
A
Mekalanos
John J
JJ
D036002:ADP Ribose Transferases / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism*; D001769:Blood / Q000382:microbiology*; D002460:Cell Line; D004847:Epithelial Cells / Q000382:microbiology; D020690:GTPase-Activating Proteins; D017353:Gene Deletion; D005964:Glucosyltransferases / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008264:Macrophages / Q000382:microbiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000382:microbiology; D011552:Pseudomonas Infections / Q000382:microbiology* / Q000503:physiopathology; D011550:Pseudomonas aeruginosa / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D014774:Virulence
D001426:Bacterial Proteins; D001427:Bacterial Toxins; C477521:ExoT protein, Pseudomonas aeruginosa; D020690:GTPase-Activating Proteins; C111504:ExoY protein, bacteria; D005964:Glucosyltransferases; D036002:ADP Ribose Transferases; C444820:exoenzyme S
J Biol Chem. 1999 Dec 17;274(51):36369-72
10593930
J Gen Microbiol. 1955 Dec;13(3):572-81
13278508
Nature. 2000 Aug 31;406(6799):959-64
10984043
Infect Immun. 2000 Oct;68(10):6066-8
10992524
Infect Immun. 2000 Dec;68(12):7100-13
11083836
Biotechniques. 2000 Nov;29(5):948-50, 952
11084852
Int J Med Microbiol. 2000 Oct;290(4-5):381-7
11111915
Nat Struct Biol. 2001 Jan;8(1):23-6
11135665
Mol Microbiol. 2001 Apr;40(1):76-85
11298277
J Infect Dis. 2001 Jun 15;183(12):1767-74
11372029
J Immunol. 2001 Aug 1;167(3):1601-8
11466382
Infect Immun. 2001 Sep;69(9):5329-34
11500402
EMBO J. 2001 Oct 1;20(19):5373-82
11574469
Crit Care Med. 2002 Mar;30(3):521-8
11990909
Biochemistry. 2002 Jul 30;41(30):9680-7
12135390
Mol Microbiol. 2002 Dec;46(5):1381-90
12453223
Dev Cell. 2003 Feb;4(2):253-63
12586068
Curr Opin Infect Dis. 2003 Apr;16(2):135-43
12734446
EMBO J. 2003 Jun 16;22(12):2959-69
12805211
J Biol Chem. 2003 Aug 29;278(35):32794-800
12807879
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3892-8
12939306
EMBO J. 2003 Oct 1;22(19):4957-67
14517235
Infect Immun. 2003 Dec;71(12):6754-65
14638761
Infect Immun. 2004 Mar;72(3):1383-90
14977942
Infect Immun. 2004 Mar;72(3):1677-84
14977975
Mol Microbiol. 1996 Dec;22(5):991-1003
8971719
Infect Immun. 1997 Feb;65(2):579-86
9009316
Gene. 1997 Feb 20;186(1):29-35
9047341
Mol Microbiol. 1997 Aug;25(3):547-57
9302017
Am J Infect Control. 1997 Dec;25(6):458-62
9437483
Infect Immun. 2005 Mar;73(3):1695-705
15731070
J Infect Dis. 1985 Oct;152(4):716-21
2995500
Infect Immun. 1996 Jan;64(1):37-43
8557368
Infect Immun. 1996 Jun;64(6):2288-94
8675339
Microbiol Rev. 1996 Sep;60(3):539-74
8840786
J Med Microbiol. 1996 Nov;45(5):359-65
8918952
J Biol Chem. 1998 Mar 27;273(13):7332-7
9516428
Infect Immun. 1998 Apr;66(4):1413-20
9529061
Microbiol Mol Biol Rev. 1998 Jun;62(2):379-433
9618447
Infect Immun. 1998 Jul;66(7):3164-9
9632581
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13899-904
9811898
Infect Immun. 1999 Feb;67(2):914-20
9916108
Infect Immun. 1999 Jun;67(6):3151-4
10338535
J Clin Invest. 1999 Sep;104(6):743-50
10491409
Plasmid. 2000 Jan;43(1):59-72
10610820